Skip to main content
. Author manuscript; available in PMC: 2022 Dec 21.
Published in final edited form as: Circulation. 2021 Oct 6;144(25):1981–1990. doi: 10.1161/CIRCULATIONAHA.121.055654

Figure 1: Effect of marine omega-3 fatty acids supplements on the risk of AF events using Knapp-Hartung adjustment for random effect model.

Figure 1:

Abbreviations: AF, atrial fibrillation; ASCEND, A Study of Cardiovascular Events in Diabetes; DHA, docosahexaenoic acid; HR, hazard ratio; GISSI-HF, Gruppo Italiano per lo Studio della Sopravvi- venza nell’Insufficienza Cardiaca; OMEMI, Omega-3 fatty acids in Elderly with Myocardial Infarction; REDUCE-IT, Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial; RP, The Risk and Prevention Study; STRENGTH, Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia; VITAL, The Vitamin D and Omega-3 Trial.